Loading company…
Neoprospecta provides microbial analysis and genomic sequencing for food safety, healthcare and pharmaceutical clients.
Neoprospecta Pesquisa e Consultoria S.A. was founded in 2011 in Florianopolis, Brazil. Its Neobiome platform uses next-generation DNA sequencing to identify microorganisms for food and beverage, healthcare and pharmaceutical customers. The company is at Seed stage, with BRL 4.000 mn raised in total, including a November 2024 round from CVentures. bioMerieux agreed to fully acquire the company in November 2024, with financial terms not disclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in